STUDIEN ZU DEN FORMEN DER VENEZIANISCHEN VEDUTENMALEREI DES 18. JAHRHUNDERTSMERX K.1970Book

Die Ostdeutsche Galerie RegensburgMERX K.Die Kunst und das schone Heim. 1977, Vol 89, Num 5, pp 285-292Article

Paul Sinkwitz. AusstellungSINKWITZ, P; MERX, K.1979, 32 p.Book

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon αMERX, K; MÜLLER, M. C; HEHLMANN, R et al.Leukemia. 2002, Vol 16, Num 9, pp 1579-1583, issn 0887-6924Article

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-CMÜLLER, M. C; GATTERMANN, N; KRAUSE, S. W et al.Leukemia. 2003, Vol 17, Num 12, pp 2392-2400, issn 0887-6924, 9 p.Article

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours : results of an extended phase-1 trialERNST, T; MERX, K; GNAD-VOGT, U et al.British journal of cancer. 2007, Vol 97, Num 11, pp 1475-1479, issn 0007-0920, 5 p.Article

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission : Spotlight on imatinib as a model for signal transduction inhibitorsPASCHKA, P; MÜLLER, M. C; GSCHAIDMEIER, H et al.Leukemia. 2003, Vol 17, Num 9, pp 1687-1694, issn 0887-6924, 8 p.Article

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilizationMÜLLER, M. C; MERX, K; WEISSER, A et al.Leukemia. 2002, Vol 16, Num 12, pp 2395-2399, issn 0887-6924, 5 p.Article